Table 3 Number (%) of typhoid fever cases with documented S. Typhi vaccination
Months pre-outcome | Parenteral, other than acetone-killed, dried | Vi capsule | Parenteral acetone-killed dried | Live oral | Unspecified formulation | Any |
|---|---|---|---|---|---|---|
6 | 11 (5.4) | 17 (8.3) | 1 (0.5) | 0 (0.0) | 0 (0.0) | 27 (13.2) |
12 | 16 (7.8) | 20 (9.8) | 3 (1.5) | 0 (0.0) | 0 (0.0) | 37 (18.1) |
18 | 17 (8.3) | 23 (11.3) | 4 (2.0) | 1 (0.5) | 0 (0.0) | 43 (21.1) |
24 | 21 (10.3) | 25 (12.3) | 5 (2.5) | 4 (2.0) | 0 (0.0) | 53 (26.0) |
36 | 32 (15.7) | 31 (15.2) | 10 (4.9) | 5 (2.5) | 4 (2.0) | 75 (36.8) |
48 | 44 (21.6) | 33 (16.2) | 15 (7.4) | 9 (4.4) | 5 (2.5) | 94 (46.1) |
Any time | 72 (35.3) | 39 (19.1) | 27 (13.2) | 18 (8.8) | 8 (3.9) | 122 (59.8) |